Introduction into European market access for medical technologies

This online on-demand 3-hour seminar gives a comprehensive overview of key concepts in market access for medical devices in Europe. Available as pre-recorded webinar or full presentation in Acrobat PDF

Market access is a complex discipline that includes topics of reimbursement, funding, health technology assessment, clinical epidemiology, and stakeholder engagement.

At the moment, there is no good introductory training in market access for medical devices in Europe. Market access professionals develop an understanding of the disciple through work experience and conferences.

European Med Tech and IVD Reimbursement Consulting bridged the gap with a seminar, aimed to give a brief, but comprehensive understanding of core concepts in the field of market access for medical devices in Europe.

The seminar includes general concepts of market access as well as some specifics of the market access situation in 10 EU countries (Austria, Belgium, England, France, Germany, Italy, Netherlands, Norway, Sweden and Switzerland).

This course is suitable for market access professionals as well as those new to the subject.

What topics are reviewed?

Reimbursement, payment mechanisms, DRG system

 

Common payment mechanisms for hospital and ambulatory services, procedural and diagnosis classifications, principles of functioning of DRG system, example of development of DRG system for TAVI 

Innovation payment schemes

Review of 15 innovative payment schemes in Europe (Austria, Belgium, England, France, Germany, Netherlands and Switzerland). For each scheme, objective and brief overview, key statistics and implications for industry is provided

Funding and willingness to pay

A brief overview of the concept of funding and funding frameworks in individual European countries (e.g. commissioning policies of NHS England, "New methods" framework in Norway)

Role of clinical and economic evidence

General requirements for clinical and economic evidence for medical devices, general tips for planning and execution of clinical trials with focus on reimbursement stakeholders

Health technology assessment

A brief overview of HTA methodology, connection of HTA with reimbursement and funding decisions, role of EUnetHTA 

Stakeholder engagement, reimbursement pathways

Considerations for stakeholder management and effective market access strategy, overview of selective reimbursement pathways and complexity of achieving reimbursement 

How seminar is delivered?

Option #1: Pre-recorded webinar

One option is to watch the seminar, which is provided as a pre-recorded webinar. The duration of the webinar is 3 hours. Seminar is available for 6 months

Option #2: Presentation in Acrobat PDF

You can also access just the educational material - the full presentation of the seminar in Acrobat PDF

View extract from the seminar

This 2-minute extract presents part of the overview of the coding for medical procedures in Europe

 

Request a quote

Click the button below to request a quote for the seminar

Do you have any remaining questions?

Check if they are answered at the main page or contact us
Check the main page
Close

50% Complete

Two Step

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.